Cargando…
Intestinal Immunity and Gut Microbiota in Atherogenesis
Atherosclerosis is a chronic inflammatory disease. Interventions targeting the inflammatory process could provide new strategies for preventing atherosclerotic cardiovascular diseases (CVD). Previously, we have reported that oral administration of anti-CD3 antibodies, or active vitamin D(3), reduced...
Autor principal: | Yamashita, Tomoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305671/ https://www.ncbi.nlm.nih.gov/pubmed/27928097 http://dx.doi.org/10.5551/jat.38265 |
Ejemplares similares
-
Bridging intestinal immunity and gut microbiota by metabolites
por: Wang, Gang, et al.
Publicado: (2019) -
Gut Microbiota Modulation on Intestinal Mucosal Adaptive Immunity
por: Wang, Li, et al.
Publicado: (2019) -
Atherogenesis: Initiating Factors
por: Waters, L. L.
Publicado: (1974) -
The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation
por: Amoroso, Chiara, et al.
Publicado: (2020) -
The Importance of the Plasma Membrane in Atherogenesis
por: Kotlyarov, Stanislav, et al.
Publicado: (2022)